รายงานการประชุมคณะกรรมการตรวจสอบ ครั้งที่ 4/2548 Ref.: SET-2018-003 February 14, 2018 Subject: Additional Disclosure “Signing on the Franchise Agreement; and the Agreement to Acquire and Dispose
Exchange of Thailand In accordance with the resolution of the Board of Directors Meeting of Inter Pharma Public Company Limited ("the Company") No. 4/2020, held on 8th June 2020, has approved the Company to
divided into 400,000 ordinary shares, valuing at Baht 10 each and fully paid. On July 12, 2019, HKP has entered into the Power Purchase Agreement for Hin Kong Power Project in Hin Kong Sub-district, Muang
share purchase agreement with the Seller on 20 June 2018 (the “Share Purchase Agreement”). The material details and conditions of the Share Purchase Agreement are as follows: (1) The Company will directly
share purchase agreement with the Seller on 20 June 2018 (the “Share Purchase Agreement”). The material details and conditions of the Share Purchase Agreement are as follows: (1) The Company will directly
share purchase agreement with the Seller on 20 June 2018 (the “Share Purchase Agreement”). The material details and conditions of the Share Purchase Agreement are as follows: (1) The Company will directly
November 12, 2019 Subject: Notification of the Resolution of the Board of Directors Meeting Re: the Investment in N.E.X.T Company Limited To: President Stock Exchange of Thailand Enclosure: Information
November 12, 2019 Subject: Notification of the Resolution of the Board of Directors Meeting Re: the Investment in N.E.X.T Company Limited (additional) To: President Stock Exchange of Thailand Enclosure
) Consolidated The Company only ( 20..) ( 20..) (20..) (20..) 1. Cash and cash equivalents 2. Long-term deposits at financial institutions 3. Securities purchased under reverse repurchase agreement 4. Investments
repurchase agreement 4. Investments in investment Securities 5. Investments in subsidiary and affiliated 6. Receivables from Clearing House 7. Securities business receivables and Derivatives business